[Form 4] Molina Healthcare, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Golden Matrix Group, Inc. (GMGI) Form 4 filing discloses that Chief Executive Officer, Director, and 10% owner Anthony Brian Goodman sold 50,000 shares of common stock on 30 June 2025 at prices ranging from $1.71-$1.80 (footnote indicates a volume-weighted average price of ≈$1.75). The transaction was reported on 2 July 2025.

Following the disposition, Goodman still controls a substantial stake: 8,854,079 shares held directly and 7,470,483 shares held indirectly through his wholly-owned entity, Luxor Capital LLC, for a combined beneficial ownership of roughly 16.32 million shares. The sale represents ≈0.3 % of his total position, suggesting portfolio management rather than a major reduction in commitment.

No derivative securities activity was reported, and the filing does not reference any Rule 10b5-1 trading plan. Luxor Capital LLC is listed as a joint filer because of its indirect ownership.

• Key take-away: A modest insider sale by the CEO; insider retains a dominant ownership position.

Positive

• CEO retains approximately 16.3 million shares, indicating continued long-term alignment with shareholders despite the small sale.

Negative

• Insider sale by the CEO could be interpreted by some investors as a bearish signal, even though the volume is minimal.

Insights

Securities Analyst

TL;DR: 0.3 % CEO share sale is immaterial; ownership remains large.

The 50 k-share sale generates roughly $87.5 k in proceeds and trims Goodman’s stake by only a few tenths of a percent. His continued 16 M-share holding keeps his economic interests strongly aligned with shareholders. Because no guidance, earnings, or strategic changes accompany the transaction, I view the filing as neutral for the stock. Insider selling often raises eyebrows, but magnitude, timing, and retained ownership suggest routine liquidity.

Corporate Governance Expert

TL;DR: Governance risk low; sale within normal insider-trading patterns.

There is no evidence of a 10b5-1 plan, yet the sale volume is modest and fully disclosed within two days, satisfying Section 16 timeliness. The CEO’s large residual stake limits potential misalignment. Absent larger or repeated disposals, I classify governance impact as non-material.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ORLANDO STEVEN J

(Last) (First) (Middle)

2180 HARVARD STREET

SUITE 400

(Street)

SACRAMENTO CA 95815

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		A(1)		180(2)	A	$306.29(3)	16,723	I	Held by trust(4)
Common Stock								1,500	I	Held by Reporting Person's 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2025 was $306.29, which resulted in a grant of 180 shares.

3. Represents the closing price of the Issuer's common stock on July 1, 2025.

4. Shares are held by Orlando Family Trust.

Remarks:

	Jeff. D. Barlow, by power of attorney for Steven J. Orlando.	07/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Golden Matrix (GMGI) shares did CEO Anthony Goodman sell?

50,000 shares of common stock were sold on 30 June 2025.

What was the average price of the GMGI shares sold?

The weighted average sale price was approximately $1.75, with transactions between $1.71 and $1.80.

How many GMGI shares does the CEO still own after the sale?

Goodman beneficially owns 8,854,079 direct shares and 7,470,483 indirect shares via Luxor Capital LLC—about 16.3 million total.

Does the filing mention a Rule 10b5-1 trading plan?

No. The form does not indicate the transaction was executed under a pre-arranged Rule 10b5-1 plan.

Is the insider sale material to Golden Matrix investors?

Given the sale represents roughly 0.3 % of the CEO’s holdings, analysts generally consider it immaterial to the investment thesis.